Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Semagacestat – Gamma Secretase Inhibitor for Alzheimer’s Disease

Drug (Brand/Generic)

Semagacestat (LY-450139)

Company/Licensee

Eli Lilly

Therapy Class

Gamma secretase inhibitor

Product Description

Anti-amyloid therapy

Current Indication

Alzheimer's disease

Market Sector

CNS

Development Status

Halted
Expand

Go Top